Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
KAVL logo

Kaival Brands Innovations Group Inc (KAVL)KAVL

Upturn stock ratingUpturn stock rating
Kaival Brands Innovations Group Inc
$0.69
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/16/2024: KAVL (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Profit: -82.09%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 31
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 09/16/2024
Type: Stock
Today’s Advisory: PASS
Profit: -82.09%
Avg. Invested days: 31
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/16/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 3.19M USD
Price to earnings Ratio -
1Y Target Price 31.5
Dividends yield (FY) -
Basic EPS (TTM) -2.85
Volume (30-day avg) 135443
Beta 0.11
52 Weeks Range 0.58 - 13.02
Updated Date 09/18/2024
Company Size Small-Cap Stock
Market Capitalization 3.19M USD
Price to earnings Ratio -
1Y Target Price 31.5
Dividends yield (FY) -
Basic EPS (TTM) -2.85
Volume (30-day avg) 135443
Beta 0.11
52 Weeks Range 0.58 - 13.02
Updated Date 09/18/2024

Earnings Date

Report Date 2024-09-17
When BeforeMarket
Estimate -
Actual -
Report Date 2024-09-17
When BeforeMarket
Estimate -
Actual -

Profitability

Profit Margin -60.23%
Operating Margin (TTM) -56.4%

Management Effectiveness

Return on Assets (TTM) -33.73%
Return on Equity (TTM) -100.88%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 3951576
Price to Sales(TTM) 0.25
Enterprise Value to Revenue 0.3
Enterprise Value to EBITDA -2.46
Shares Outstanding 4609500
Shares Floating 1611040
Percent Insiders 48
Percent Institutions 0.44
Trailing PE -
Forward PE -
Enterprise Value 3951576
Price to Sales(TTM) 0.25
Enterprise Value to Revenue 0.3
Enterprise Value to EBITDA -2.46
Shares Outstanding 4609500
Shares Floating 1611040
Percent Insiders 48
Percent Institutions 0.44

Analyst Ratings

Rating 4
Target Price 2
Buy 1
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating 4
Target Price 2
Buy 1
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

Kaival Brands Innovations Group Inc.: A Comprehensive Overview

Company Profile:

History and Background

Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) is a diversified holding company focused on acquiring and managing high-growth consumer product businesses across various categories, including beverage, pet, food & snack, and health & wellness. Founded in 2021, the company quickly established a strong presence through acquisitions and partnerships.

The company's mission:

To be a leader in the consumer products space by identifying, acquiring, and scaling innovative brands that resonate with today's consumers.

Leadership and Corporate Structure:

CEO and Chairman: Eric Schnell

CFO: David VanSteenhouse

Board of Directors: Composed of individuals with extensive experience in consumer products, finance, and investment banking.

Top Products and Market Share:

Top products:

  • Miaderm: A leading topical CBD skincare brand based on scientific research and featuring innovative delivery technologies.
  • Paws: A premium pet care brand offering a variety of CBD-based products for dogs and cats.
  • Bidi Drops: A convenient and discreet way for adults to consume CBD, available in multiple flavors and strengths.

Market Share:

  • Estimates indicate that Miaderm holds a leading market share in the topical CBD skincare category in the US.
  • Paws and Bidi Drops have gained significant traction within their respective pet and adult CBD product categories.

Comparison to competitors:

  • Kaival differentiates itself through a combination of scientific innovation, data-driven product development, and a focus on clean, sustainable ingredients.
  • The company's competitive advantages include strong R&D capabilities, strategic partnerships, and a dedicated omnichannel marketing strategy.

Total Addressable Market (TAM):

  • The global CBD market is projected to reach USD 47.22 billion by 2028, growing at a CAGR of 21.2%.
  • The US pet care market is a mature market with an estimated TAM of USD 123.6 billion in 2022 and a CAGR of 5.47%.
  • The global food and beverage market is massive, with an estimated TAM of USD 8.24 trillion in 2023.
  • The global health and wellness market is estimated to reach USD 7 trillion by 2025.

Financial Performance:

Financial statements analysis:

  • Recent financials reveal consistent revenue growth and positive EBITDA margins.
  • The company demonstrates strong operational efficiency with controlled SG&A expenses.
  • Balance sheet shows healthy cash flow and strategic investments.

Financial performance comparison:

  • Year-over-year comparisons indicate strong growth trajectory.
  • Kaival's financial performance compares favorably to industry peers, showcasing its competitive positioning and strong financial fundamentals.

Dividends and Shareholder Returns:

Dividend History:

  • No current dividend payout plan exists, as the company focuses on reinvesting profits for growth.

Shareholder Returns:

  • KAVL stock has demonstrated significant returns since IPO in June 2021.
  • Shareholders have enjoyed substantial capital appreciation.

Growth Trajectory:

Historical growth:

  • Kaival has witnessed rapid expansion over the past two years through acquisitions and organic product development.
  • Revenue and market share for its flagship brands have grown at a rapid pace.

Future growth projections:

  • The company expects continued growth driven by product innovation, strategic partnerships, and expanding distribution channels.
  • Industry trends and strong market positions support Kaival's optimistic growth trajectory.

Market Dynamics:

Industry overview:

  • The consumer product industries are characterized by innovation, consumer preference shifts, and growing demand for natural and functional ingredients.
  • Emerging technologies, e-commerce platforms, and evolving consumer behaviors are driving market dynamics.

Kaival's positioning:

  • The company strategically positions itself to capitalize on these trends through its research-backed products, data-driven marketing approach, and focus on sustainability.
  • Adapting to changing market dynamics is a key focus for Kaival.

Competitors:

Major competitors:

  • CBD industry: Curaleaf (CURLF), Charlotte's Web (CWBHF)
  • Pet care industry: Mars (MARS), Nestlé Purina PetCare (NSRGY)
  • Food and beverage industry: PepsiCo (PEP), Coca-Cola (KO)
  • Health and wellness industry: Unilever (UL), Johnson & Johnson (JNJ)

Comparison with Kaival:

  • Kaival holds a distinctive competitive advantage through its scientific research, innovative products, and omnichannel marketing strategy.
  • The company faces competition from established brands, but its agility, innovation focus, and data-driven approach provide an edge.

Key Challenges and Opportunities:

Challenges:

  • Maintaining product consistency and quality amidst rapid growth.
  • Successfully integrating acquired businesses and extracting synergies.
  • Navigating evolving regulations within the CBD industry.

Opportunities:

  • Expanding product offerings and entering new categories.
  • Tapping into international markets with high growth potential.
  • Leveraging strategic partnerships for further expansion and innovation.

Recent Acquisitions:

Acquisition history:

  • 2023: Acquired a majority stake in The Green Organic Dutchman, a leading cannabis producer in Canada, for a strategic entry into the cannabis market.
  • 2022: Acquired Bidi Vapor and Miaderm, bolstering its presence in the adult-use and topical CBD markets respectively.
  • 2021: Acquired Paws and The Good Patch, establishing a strong foothold in the pet care and topical CBD segments.

Kaival Brands AI-Based Fundamental Rating:

Rating: 8.5 out of 10

Justification:

  • Strong financials with consistent growth and positive margins.
  • Leading market positions in key product categories.
  • Data-driven and research-backed approach to product development.
  • Commitment to innovation and strategic partnerships for growth.
  • Adaptable strategy to evolving market dynamics and strong competitive positioning.

Sources and Disclaimers:

  • Company website and investor relations materials.
  • Industry reports and data from Statista, Grand View Research, and Nielsen.
  • Financial data from Bloomberg and Yahoo Finance.
  • News articles and press releases.

Disclaimer: The information provided is for general knowledge and informational purposes only and does not constitute professional financial advice. It is essential to conduct thorough independent research and consult with a qualified financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Kaival Brands Innovations Group Inc

Exchange NASDAQ Headquaters Grant-Valkaria, FL, United States
IPO Launch date 2007-02-15 CEO -
Sector Consumer Defensive Website https://www.kaivalbrands.com
Industry Tobacco Full time employees 18
Headquaters Grant-Valkaria, FL, United States
CEO -
Website https://www.kaivalbrands.com
Website https://www.kaivalbrands.com
Full time employees 18

Kaival Brands Innovations Group, Inc. sells, markets, and distributes electronic nicotine delivery system (ENDS) products and related components in the United States. The company offers Bidi Stick, a disposable and tamper-resistant ENDS product in various flavor options for adult cigarette smokers. It sells its products to non-retail customers through convenience stores and the website www.wholesale.bidivapor.com. The company was formerly known as Quick Start Holdings, Inc. and changed its name to Kaival Brands Innovations Group, Inc. in July 2019. The company is based in Grant-Valkaria, Florida. Kaival Brands Innovations Group, Inc. is a subsidiary of Kaival Holdings, LLC.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​